Articles & Video
Back to business? Demand for trials returning, says Icon
Icon says demand is recovering with bookings for its own services as well as those of soon-to-be acquired PRA continuing to climb in the second quarter.
Medpace says careful project selection is key
Medpace says taking on the right clinical projects, working with a range of technologies and across a broad range of therapeutic areas is core to its strategy.
Survey highlights lack of minority leadership in life science spaceClinical Insider
Trial payment firm Greenphire to be acquired by PEClinical Insider
Eurofins to help expand COVID-19 testing in US schools and beyondClinical Insider
PE firm Keensight taking major stake in Dutch CRO SymeresClinical Insider
Castor: Demand for decentralized trial tech growing due to pandemic
Clinical Insider is a weekly newsletter devoted to the clinical development of pharmaceuticals consisting of unbiased news written by trained journalists. Clinical Insider is part of Informa Connect a division of Informa, PLC. Informa’s leading brands and expert teams operate events and exhibitions, deliver intelligence-based products and data-driven services, convene communities in person and digitally and provide access to cutting-edge research for specialist customer communities worldwide.